The role of prostate HistoScanning in detecting prostate cancer

Cover Page

Cite item

Full Text

Abstract

The early stage prostate cancer (PC) does not usually have clinical manifestations. The symptoms are usually associated with benign prostatic hyperplasia. The symptoms of infravesical obstruction, as well as the symptoms associated with the local tumor progression (tumor invasion into the neck of the urinary bladder, urethra, etc.) and during the tumor progression there is the occurrence of distant metastasis. Introduction of the program concerning the early PC diagnosis, including digital rectal examination (DRE), determination of the prostatic specific antigen level and performance of transrectal ultrasound made it possible to diagnosis PC at early stage and to offer the radical methods of PC treatment to patients. The appearance of new non-invasive method of PC visualization using HistoScanning showed the considerable potential in the diagnosis of prostate cancer and treatment selection, and during the planning of the surgical procedures and follow-up of patients. The modernization of existed technique has allowed perform target transrectal prostate biopsy under the control of HistoScanning using fewer injections and higher diagnostic value.

About the authors

A. V Govorov

A.I.Evdokimov Moscow State Medical and Dental University of the Ministry of Health of the Russian Federation

Email: alexgovorov@newmail.ru
канд. мед. наук, доц. каф. урологии ГБОУ ВПО МГМСУ им. А.И.Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

A. O Vasilyev

A.I.Evdokimov Moscow State Medical and Dental University of the Ministry of Health of the Russian Federation

Email: alexvasilyev@me.com
канд. мед. наук, ассистент каф. урологии ГБОУ ВПО МГМСУ им. А.И.Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

A. V Sadchenko

City clinical hospital №50 of the Department of Health of Moscow

Email: doc.sadchenko@yandex.ru
канд. мед. наук, врач-уролог консультативно-диагностического центра ГБУЗ ГКБ №50 127206, Russian Federation, Moscow, ul. Vucheticha, d. 21

E. A Prilepskaya

A.I.Evdokimov Moscow State Medical and Dental University of the Ministry of Health of the Russian Federation

Email: prilepskayae@mail.ru
ассистент каф. урологии ГБОУ ВПО МГМСУ им. А.И.Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

M. V Kovylina

A.I.Evdokimov Moscow State Medical and Dental University of the Ministry of Health of the Russian Federation

Email: dr.kovylina@gmail.com
канд. мед. наук, ассистент каф. урологии ГБОУ ВПО МГМСУ им. А.И.Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

D. Yu Pushkar

A.I.Evdokimov Moscow State Medical and Dental University of the Ministry of Health of the Russian Federation

Email: pushkardm@mail.ru
д-р мед. наук, проф., зав. каф. урологии ГБОУ ВПО МГМСУ им. А.И.Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

References

  1. Catalona W.J, Smith D.S, Ratliff T.L et al. Measurement of prostate - specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991; 324: 1156-61.
  2. Wolf A, Wender R.C, Etzioni R.B et al. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010. CA Cancer J Clin 2010; 60: 70-98.
  3. Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2013 году (заболеваемость и смертность). М.: МНИОИ им. П.А.Герцена, филиал ФГБУ «ФМИЦ им. П.А.Герцена» Минздрава России, 2015.
  4. Говоров А.В., Васильев А.О., Пушкарь Д.Ю. Рак предстательной железы: коротко о главном. Справ. поликлин. врача. 2014; 6: 36-40.
  5. Braeckman J, Autier P, Zatura F et al. Evaluation of HistoScanningTM for the detection, location and volume estimation of prostate cancer: Results of the open phase of the PHS-02 study. J Clin Oncol 2011; 29 (Suppl. 7): abstr. 55.
  6. Wink M, Frauscher F, Cosgrove D et al. Contrast - enhanced ultrasound and prostate cancer; a multicentre European research coordination project. Eur Urol 2008; 54: 982-93.
  7. Frauscher F, Klauser A, Volgger H et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 2002; 167: 1648-52.
  8. Simmons L.A, Autier P, Zatura F et al. Detection, localization and characterization of prostate cancer by Prostate HistoScanningTM. BJU Int 2012; 110 (1): 28-35.

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies